Rinvoq eczema cost?

Rinvoq (upadacitinib) is a brand-name prescription antibiotic? No—it's a JAK inhibitor used for moderate-to-severe eczema (atopic dermatitis) among other conditions. Price varies a lot by country, dose, and whether you have insurance.

In the United States (typical case for eczema):
- List price (before any discounts): about $60,000–$75,000 per year for the usual 15 mg once-daily dose (roughly $5,000–$6,250 per month).
- With insurance and/or manufacturer savings programs: your out-of-pocket can be quite a bit lower, but it varies widely. Some people pay hundreds per month, others more depending on deductible, copay/coinsurance, and eligibility for savings programs.

Ways to reduce cost:
- Check with your insurer about coverage and required prior authorization.
- Ask your pharmacist for the cash price and compare with discount programs (GoodRx, RxSaver, etc.).
- See if you qualify for AbbVie’s patient savings program or Rinvoq manufacturer assistance (eligibility rules apply).
- Your doctor can sometimes suggest alternatives with different costs if price is a barrier (e.g., Dupixent or other therapies, depending on your situation).

If you tell me your country, city, insurance type, and the prescribed dose (15 mg daily is common for eczema), I can give a more tailored estimate and point you to specific savings options.